BioCentury | Sep 16, 2020
Deals

Sept. 15 Quick Takes: NIH consortium seeks schizophrenia biomarkers; plus Boehringer-Click, Takeda, Nestlé-Aimmune, 89bio, Cellinta, Cullinan Florentine, Bayer-Systems Oncology

...by SV Health Investors and joined by Cancer Research UK...
BioCentury | Sep 5, 2020
Translation in Brief

Matt Disney’s microRNA-targeting angiogenesis compound; Arrakis’ platform to find compounds’ RNA targets; dual target CAR Ts for HIV and more

...Cancer Research UK anti-arginase mAb for tumorsScientists from the Cancer Research UK-AstraZeneca...
...A Danielle Golovin Arrakis Therapeutics Inc. The Scripps Research Institute AstraZeneca plc Cancer Research UK Vascular...
BioCentury | Aug 27, 2020
Product Development

Cancer Research UK, NCI partner for $550M Grand Cancer Challenges initiative

...By stephen hansen, associate editor The National Cancer Institute has joined forces with Cancer Research UK to fund...
...of the microbiome in cancer progression, or mapping out 3D models of different tumor types. Stephen Hansen Cancer Research UK National...
BioCentury | Aug 21, 2020
Product Development

Merck’s north London pick for discovery center could accelerate growth of surrounding research hub

...Quarter” persuaded the company to pick the location. Its neighbors will include the Francis Crick Institute, Cancer Research UK...
BioCentury | Jul 31, 2020
Distillery Therapeutics

Fat metabolism enzyme DECR1 as castration-resistant prostate cancer target

...Hing Y. Leung, Cancer Research UK Beatson Institute, Glasgow, U.K.; University of Glasgow, Glasgow, U.K. email: h.leung@beatson.gla.ac.uk Claire Quang Cancer Research UK University...
BioCentury | Apr 25, 2020
Targets & Mechanisms

Trends to surf for at AACR 2020

...will feature presentations by teams affiliated with cancer evolution pioneer Charles Swanton, chief clinician at Cancer Research UK...
BioCentury | Apr 11, 2020
Management Tracks

Harpal Kumar named president of Grail Europe; plus Notable, Oncoceutics, ReAlta, Parker Institute

...Europe, the Middle East and Africa at Johnson & Johnson (NYSE:JNJ) and was CEO of Cancer Research UK...
BioCentury | Mar 19, 2020
Management Tracks

Leng will become NICE chief executive; plus BMS, Sofinnova, Medicxi, PTC, Orchard and more

...and immunotherapy at University College London Cancer Institute and a senior cancer research fellow at Cancer Research UK...
BioCentury | Feb 26, 2020
Deals

Bicycle’s bicyclic peptides attract Genentech as first corporate immuno-oncology partner

...and fit in a normal immune synapse.” Kevin Lee, Bicycle In January, Bicycle announced that Cancer Research UK...
BioCentury | Jan 24, 2020
Finance

iOnctura taps European syndicate for series A to bring two ‘best-in-class’ programs to the clinic

...year. Created in 2017 by former Merck KGaA (Xetra:MRK) executive Catherine Pickering in partnership with Cancer Research UK...
Items per page:
1 - 10 of 400
BioCentury | Sep 16, 2020
Deals

Sept. 15 Quick Takes: NIH consortium seeks schizophrenia biomarkers; plus Boehringer-Click, Takeda, Nestlé-Aimmune, 89bio, Cellinta, Cullinan Florentine, Bayer-Systems Oncology

...by SV Health Investors and joined by Cancer Research UK...
BioCentury | Sep 5, 2020
Translation in Brief

Matt Disney’s microRNA-targeting angiogenesis compound; Arrakis’ platform to find compounds’ RNA targets; dual target CAR Ts for HIV and more

...Cancer Research UK anti-arginase mAb for tumorsScientists from the Cancer Research UK-AstraZeneca...
...A Danielle Golovin Arrakis Therapeutics Inc. The Scripps Research Institute AstraZeneca plc Cancer Research UK Vascular...
BioCentury | Aug 27, 2020
Product Development

Cancer Research UK, NCI partner for $550M Grand Cancer Challenges initiative

...By stephen hansen, associate editor The National Cancer Institute has joined forces with Cancer Research UK to fund...
...of the microbiome in cancer progression, or mapping out 3D models of different tumor types. Stephen Hansen Cancer Research UK National...
BioCentury | Aug 21, 2020
Product Development

Merck’s north London pick for discovery center could accelerate growth of surrounding research hub

...Quarter” persuaded the company to pick the location. Its neighbors will include the Francis Crick Institute, Cancer Research UK...
BioCentury | Jul 31, 2020
Distillery Therapeutics

Fat metabolism enzyme DECR1 as castration-resistant prostate cancer target

...Hing Y. Leung, Cancer Research UK Beatson Institute, Glasgow, U.K.; University of Glasgow, Glasgow, U.K. email: h.leung@beatson.gla.ac.uk Claire Quang Cancer Research UK University...
BioCentury | Apr 25, 2020
Targets & Mechanisms

Trends to surf for at AACR 2020

...will feature presentations by teams affiliated with cancer evolution pioneer Charles Swanton, chief clinician at Cancer Research UK...
BioCentury | Apr 11, 2020
Management Tracks

Harpal Kumar named president of Grail Europe; plus Notable, Oncoceutics, ReAlta, Parker Institute

...Europe, the Middle East and Africa at Johnson & Johnson (NYSE:JNJ) and was CEO of Cancer Research UK...
BioCentury | Mar 19, 2020
Management Tracks

Leng will become NICE chief executive; plus BMS, Sofinnova, Medicxi, PTC, Orchard and more

...and immunotherapy at University College London Cancer Institute and a senior cancer research fellow at Cancer Research UK...
BioCentury | Feb 26, 2020
Deals

Bicycle’s bicyclic peptides attract Genentech as first corporate immuno-oncology partner

...and fit in a normal immune synapse.” Kevin Lee, Bicycle In January, Bicycle announced that Cancer Research UK...
BioCentury | Jan 24, 2020
Finance

iOnctura taps European syndicate for series A to bring two ‘best-in-class’ programs to the clinic

...year. Created in 2017 by former Merck KGaA (Xetra:MRK) executive Catherine Pickering in partnership with Cancer Research UK...
Items per page:
1 - 10 of 400